- Home
- AZI vs NRSN Comparison
AZI vs NRSN Comparison
Compare AZI & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZI
- NRSN
- Stock Information
- Founded
- AZI 2010
- NRSN 2017
- Country
- AZI China
- NRSN Israel
- Employees
- AZI N/A
- NRSN N/A
- Industry
- AZI
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- AZI
- NRSN Health Care
- Exchange
- AZI Nasdaq
- NRSN Nasdaq
- Market Cap
- AZI 25.6M
- NRSN 29.8M
- IPO Year
- AZI 2024
- NRSN 2021
- Fundamental
- Price
- AZI $0.08
- NRSN $0.95
- Analyst Decision
- AZI
- NRSN Buy
- Analyst Count
- AZI 0
- NRSN 2
- Target Price
- AZI N/A
- NRSN $14.00
- AVG Volume (30 Days)
- AZI 30.7M
- NRSN 196.1K
- Earning Date
- AZI 01-01-0001
- NRSN 12-17-2025
- Dividend Yield
- AZI N/A
- NRSN N/A
- EPS Growth
- AZI N/A
- NRSN N/A
- EPS
- AZI N/A
- NRSN N/A
- Revenue
- AZI $156,466,000.00
- NRSN N/A
- Revenue This Year
- AZI N/A
- NRSN N/A
- Revenue Next Year
- AZI N/A
- NRSN N/A
- P/E Ratio
- AZI N/A
- NRSN N/A
- Revenue Growth
- AZI 32.90
- NRSN N/A
- 52 Week Low
- AZI $0.08
- NRSN $0.80
- 52 Week High
- AZI $3.20
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- AZI 23.00
- NRSN 31.86
- Support Level
- AZI $0.08
- NRSN $0.91
- Resistance Level
- AZI $0.15
- NRSN $1.14
- Average True Range (ATR)
- AZI 0.02
- NRSN 0.07
- MACD
- AZI -0.00
- NRSN -0.02
- Stochastic Oscillator
- AZI 5.96
- NRSN 11.40
About AZI Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares
Autozi Internet Technology (Global) Ltd provides high-quality, affordable, and professional one-stop automotive products and services through online and offline channels in China. Leveraging its online supply chain cloud platform, SaaS platforms, and the network of MBS stores, It has established an ecosystem of lifecycle automotive services by connecting automotive manufacturers, auto parts manufacturers, and insurance companies with MBS stores and various automotive owners. Its business segments include new car sales, auto parts and auto accessories sales, and automotive insurance-related services. The majority of revenue is from the new car sales segment, and auto parts & auto accessories sales.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.